title: [Influence of neural regulation on anti-arrhythmic effects of GABA in rats].
abstract: In anesthetized rats, GABA 10 mg.kg-1 iv delayed the onset of ventricular premature (VP) (P less than 0.01) and ventricular tachycardia (VT) (P less than 0.01) and reduced the incidence of ventricular fibrillation (VF) (P less than 0.05). The anti-arrhythmic effects of GABA remained after cervical vagotomy, iv hexamethonium 10 mg.kg-1 or destruction of CNS. It was also seen on pithed rats. In Langendorff heart, GABA 100 mg.L-1 elevated the threshold doses of aconitine required to induce VT (P less than 0.01), VF (P less than 0.01), and heart stop (HS) (P less than 0.01). These results suggest that iv GABA counteracts aconitine-induced arrhythmia directly on the heart, not related to the neural regulation.
authors.affiliation: Department of Pharmacology, Beijing Heart Lung Blood Vessel Medical Center, China.
authors.forename: J R
authors.initials: JR
authors.lastname: Meng
authors.forename: T
authors.initials: T
authors.lastname: Wu
authors.forename: L
authors.initials: L
authors.lastname: Huang
mesh_terms: D000157:Aconitine; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000517:prevention & control*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D051381:Rats; D014628:Vagotomy / Q000379:methods; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
chemical_list: D000889:Anti-Arrhythmia Agents; D006584:Hexamethonium Compounds; D005680:gamma-Aminobutyric Acid; D000157:Aconitine